Magnolia Medical Technologies Revenue and Competitors
Estimated Revenue & Valuation
- Magnolia Medical Technologies's estimated annual revenue is currently $51.1M per year.
- Magnolia Medical Technologies's estimated revenue per employee is $313,750
- Magnolia Medical Technologies's total funding is $117.3M.
Employee Data
- Magnolia Medical Technologies has 163 Employees.
- Magnolia Medical Technologies grew their employee count by 9% last year.
Magnolia Medical Technologies's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO & Co-Founder | Reveal Email/Phone |
2 | Associate VP Clinical Strategy and Customer Relations | Reveal Email/Phone |
3 | Sr VP Operations and Product Develppment | Reveal Email/Phone |
4 | EVP, Commercial | Reveal Email/Phone |
5 | VP, Marketing | Reveal Email/Phone |
6 | Director Strategic Accounts | Reveal Email/Phone |
7 | Business Director | Reveal Email/Phone |
8 | Business Director | Reveal Email/Phone |
9 | Business Director | Reveal Email/Phone |
10 | Sr. Director, Quality and Regulatory | Reveal Email/Phone |
Magnolia Medical Technologies Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $6M | 48 | 118% | $14.9M | N/A |
#2 | $3.6M | 29 | -71% | $243M | N/A |
#3 | $54.6M | 174 | -30% | $211.3M | N/A |
#4 | $65.9M | 210 | 11% | $35.5M | N/A |
#5 | $5.5M | 22 | 47% | $3.52M | N/A |
#6 | $22.3M | 89 | N/A | N/A | N/A |
#7 | $10M | 40 | 5% | N/A | N/A |
#8 | $98.9M | 394 | 17% | N/A | N/A |
#9 | $8.8M | 35 | 13% | $34.8M | N/A |
#10 | $8.5M | 34 | 21% | N/A | N/A |
What Is Magnolia Medical Technologies?
Magnolia Medical Technologies develops innovative medical products that achieve predictable, high-quality outcomes. The company's first product SteriPath is the only clinically proven blood culture collection solution that maintains consistent, sustainable contamination rates as low as 0.2%. By enabling providers to consistently execute best practices, SteriPath virtually eliminates false positives--mitigating previously unavoidable clinical and financial risks, reducing unnecessary treatment, and ensuring optimal patient outcomes.
keywords:N/A
$117.3M
Total Funding
163
Number of Employees
$51.1M
Revenue (est)
9%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Magnolia Medical Technologies News
SEATTLE, April 6, 2022 /PRNewswire/ -- Magnolia Medical Technologies, Inc., inventors of Steripath®, the only FDA 510(k)-cleared device...
SEATTLE, July 29, 2021 /PRNewswire/ -- Magnolia Medical Technologies, Inc., inventors of Steripath®, the only FDA 510(k)-cleared device platform indicated to reduce blood culture contamination1 for sepsis testing, announces the commercial availability of its new Steripath® Micro Initial Specim ...
SEATTLE, June 9, 2021 /PRNewswire/ -- Magnolia Medical Technologies, Inc., inventors of Steripath®, the only FDA 510(k)-cleared device platform indicated to reduce blood culture contamination,1 announced today continued clinical efficacy data supporting multiple, peer-reviewed clinical studies ...
SEATTLE, April 14, 2021 /PRNewswire/ -- Magnolia Medical Technologies, Inc. recently launched a new multi-media advertising campaign to promote the benefits of the Steripath® Initial Specimen Diversion Device® (ISDD®) platform. Built around the theme "Diverted", the campaign underscores the c ...
Other Companies in Seattle
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $45M | 163 | 7% | N/A |
#2 | $42M | 163 | N/A | N/A |
#3 | $26.2M | 164 | 21% | N/A |
#4 | $26.2M | 164 | 6% | N/A |
#5 | $26.3M | 165 | 29% | N/A |